Jim Simons's position in Foghorn Therapeutics is currently worth $794k. That's 0.00% of their equity portfolio (2257th largest holding). Jim Simons started to build up the position in Foghorn Therapeutics in Q2 2024 and continued to invest until Q1 2026. Since then they sold 28.5k shares. The investor's estimated purchase price is $1.97M, resulting in a loss of 60%.